Sustained responses to interferon-alpha occur in 10% to 25% of patients with chronic hepatitis C, but the long-term outcome is not well defined. We evaluated the long-term clinical, histological, and virological outcomes of 10 patients with chronic hepatitis C who were treated between 1984 and 1987
Pericarditis After Therapy with Interferon-α for Chronic Hepatitis C
✍ Scribed by A. Boonen; R. W. Stockbrügger; Sj. van der Linden
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 29 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive
The aims of this pilot study were to evaluate the safety and efficacy of interferon-alpha 2b for treatment of hepatitis C virus infection in liver transplant recipients, to monitor changes in hepatitis C virus RNA levels with treatment and to determine pretreatment parameters predictive of a complet